FDA Approves Iron-Based Contrast Agent for Brain MRI
The ferumoxytol injection is indicated for adults with known or suspected malignant brain neoplasms to visualize lesions with a disrupted blood-brain barrier.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed